Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives may cause hair loss in women.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hair growth dysfunction involves various conditions with limited treatment options.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.